Clinical Trials Logo

Drug Resistant Epilepsy clinical trials

View clinical trials related to Drug Resistant Epilepsy.

Filter by:

NCT ID: NCT04553354 Not yet recruiting - Clinical trials for Drug Resistant Epilepsy

Cortical Resections in Drug Resistant Epilepsy

Start date: September 10, 2020
Phase:
Study type: Observational

The aim of the study is to evaluate safety and efficacy of epilepsy surgery in the form of cortical resections in patients with refractory epilepsy and to review outcomes of resection procedures in focal epilepsy.

NCT ID: NCT04545346 Completed - Clinical trials for Randomized Controlled Trial

The Potential of a Low Glutamate Diet as a Treatment for Pediatric Epilepsy

Start date: October 15, 2020
Phase: N/A
Study type: Interventional

The study is investigating if following the low glutamate diet for 1 month, as compared to care as usual, can improve seizure frequency, severity, and duration; cognitive functioning; and/or quality of life in children with epilepsy.

NCT ID: NCT04542629 Not yet recruiting - Refractory Epilepsy Clinical Trials

Comparative Study of Dietary and Immunological Management of Refractory Epilepsy in Children

Start date: October 1, 2020
Phase: Phase 4
Study type: Interventional

1. Comparison of the efficacy of Rituximab and ketogenic diet in controlling refractory seizures versus the traditional lines as corticosteroid and trace elements. 2. Improving the management of children with refractory seizures

NCT ID: NCT04500119 Enrolling by invitation - Clinical trials for Epilepsy Intractable

Neuronal Mechanisms of Human Episodic Memory

Start date: August 12, 2020
Phase: N/A
Study type: Interventional

The purpose the research is to better understand how the human brain accomplishes the basic cognitive tasks of learning new information, recalling stored information, and making decisions or choices about presented information. These investigations are critical to better understand human cognition and to design treatments for disorders of learning and memory.

NCT ID: NCT04496310 Recruiting - Epilepsy Clinical Trials

Tele-epic (Telemedicine for Epilepsy Care)

Tele-epic
Start date: July 9, 2020
Phase: N/A
Study type: Interventional

Epilepsy is a chronic condition that requires consistent follow-up aimed at seizure control, surveillance of comorbidities, monitoring of antiepileptic drugs (AED) levels and side effects. Patients may encounter difficulties to be assessed adequately and the disease burden is increased by the need for travelling across the country for medical consultations. Driving restrictions are a further limit to access specialized Centers able to provide an integrated approach focused on patient needs. Telemedicine (TM) offers an invaluable support to patient follow-up, joining the sparse distribution of patients in the country with the prompt availability of a team of experts. The project assesses, through a randomized controlled trial, the non-inferiority of TM in monitoring seizure control compared to usual (face-to-face) care. This approach, coupled with a new self home-sampling method for the measurement of AED levels, will reduce health care costs and simplify patients management.

NCT ID: NCT04457687 Available - Clinical trials for Drug Resistant Epilepsy

Extended Access Program With Lorcaserin For The Treatment of Dravet Syndrome and Other Refractory Epilepsies

Start date: n/a
Phase:
Study type: Expanded Access

The primary purpose of this study is to provide continued access of lorcaserin to participants with Dravet syndrome and other refractory epilepsies.

NCT ID: NCT04451278 Recruiting - Epilepsy Clinical Trials

RESting-state Functional MRI for Prediction of Post-surgical Prognosis In Pediatric Drug-Resistant Epilepsy

RESPIRE
Start date: October 30, 2020
Phase:
Study type: Observational

Resting-state functional MRI (r-fMRI) has emerged in recent years to analyze resting networks. It allows, without active participation of the patients, to identify and analyze the different functional brain networks. The analysis of r-fMRI can be done thanks to the graph theory, which is based on the based on the calculation of quantifiable parameters applied to the functional network studied, making it possible to assess its effectiveness. To the knowledge of the investigators, no study has used graph theory applied to r-fMRI data in order to obtain parameters useful for the useful parameters for the individual prognosis of children who have to be operation for drug-resistant lesional epilepsy.

NCT ID: NCT04406948 Withdrawn - Clinical trials for Children and Adolescents With Resistant Epilepsies

Study of Safety and Efficacy of MGCND00EP1 as an Add on Treatment in Children and Adolescents With Resistant Epilepsies

Start date: May 30, 2024
Phase: Phase 2
Study type: Interventional

EudraCT: 2018-003887-29 Objective:To evaluate the safety and efficacy of: MGCND00EP1 from MGC PHARMACEUTICALS d.o.o. Study Design: Randomized, double blind, placebo controlled parallel grouped study Sample Size: 103 subjects Study Population: Children from 1 year to 18 years of age Comparator Product :Placebo solution, oral IMP Product : MGCND00EP1 (each ml of solution containing 100 mg of cannabidiol and 5 mg of (-)-trans-Δ9- tetrahydrocannabinol as active substance) from MGC PHARMACEUTICALS D.O.O. According to dosing scheme up to 25 mg/kg BW per day or maximum daily dose 800 mg (whichever smaller) for 6 weeks titration and 6 weeks of treatment, oral administration

NCT ID: NCT04399954 Completed - Ketogenic Dieting Clinical Trials

Evaluation of Ketoflo

Ketoflo
Start date: February 24, 2020
Phase: N/A
Study type: Interventional

For 28 days, 30 participants aged 3 to 18 years of age (inclusive) with a condition requiring a ketogenic diet will incorporate Ketoflo into their usual dietary regime. Ketoflo is a nutritionally complete Food For Special Medical Purposes and is suitable for administration by both tube feeding and use as a sip feed. Data on gastrointestinal tolerance, participants adherence to recommended intakes and their thoughts on the product's palatability will be self-reported in Daily Study Diaries.

NCT ID: NCT04398667 Terminated - Refractory Epilepsy Clinical Trials

European Non-interventional Study on Refractory Epilepsy With Developmental Delay

Start date: March 14, 2019
Phase:
Study type: Observational

This is a multinational, multicentre, non-interventional, retrospective data collection (manual Medical Chart Review).